Vogt, Peter (Epigenomics 201601 Investor + Public Relations) |
Public Relations Manager / Investor Relations Manager |
Epigenomics (Group) |
Germany |
Vogt, Reinhard (Dynamk Capital 202205 Managing Director + Scientific Industries 202104 Chairman before Sartorius) |
Sales Manager / Marketing Manager |
Dynamk Capital LLC |
United States (USA) |
Voigt, Alexander (HH2E 202206 Board Member + Co-Founder) |
Board member, executive |
HH2E (Group) |
Germany |
Voigt, Marc (Caprotec 201107– Managing Director + CFO + COO before Medical Enzymes AG before Revotar) |
Managing Director |
Caprotec Bioanalytics GmbH |
Germany |
Voigt, Thor (Boehringer 1992–201903 CMO RETIRED 4/19) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
Voigt, Tobias (Sachsen (govt) 201905 at Technologiegründerfonds Sachsen) |
n. a. |
Saxony (govt region) |
Germany |
Volckmann, Jacques (Sanofi 202312 VP RnD France) |
Research & Development Manager |
Sanofi (Group) [since May 2011] |
France |
Volckmar, Klaus (LabWare 201003 Head German Office) |
President/Director/Head Business Group/Unit/Division |
LabWare (Group) |
Germany |
Voliotis, Dimitris (CureVac 201901– CDO before Eisai Inc + 12years at Bayer HealthCare) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
CureVac (Group) |
United States (USA) |
Vollertsen, Frank (BIAS 201104 Managing Director) |
Managing Director |
BIAS Bremer Institut für angewandte Strahltechnik GmbH |
Germany |
Vollmer, Jörg (Abalos Therapeutics 201910– CSO before Rigontec + Nexigen) |
Managing Director |
Abalos Therapeutics GmbH |
Germany |
Volmer, Dietrich (Saarland Univ 201005– Professor for Analytical Chemistry before Univ Cambridge before Dalhousie Univ) |
Professor |
Saarland University (Universität des Saarlandes) |
Germany |
Volpi, Mike (angel investor) |
n. a. |
Reliant AI (Group) |
Canada |
von Alvensleben, Konstantin (Riemser Pharma 202001 Managing Director (CEO) before Takeda Pharma GmbH) |
Managing Director |
Esteve (Group) |
Germany |
von Baumbach, Hubertus (Boehringer Ingelheim 201609 Chairman before Managing Director Finance) |
Managing Director |
Boehringer Ingelheim (Group) |
Germany |
von Berg, Martin (Gilde Investment, 202207– Investment Manager at Gilde Healthcare in Ffm before 3i + Halder + BofA) |
Investment Manager |
Gilde Investment (Group) |
Germany |
von Bohlen, Friedrich (Molecular Health 202405 CEO formerly Dievini before Lion Bioscience) |
Investment Manager |
Molecular Health (Group) |
Germany |
von Bonin, Arne (Actelion 201608– CSO of Vaxxilon before Affiris + Bayer HealthCare + Schering) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Idorsia (Group) |
Switzerland |
von Braun, Joachim (Chairman of German Bioeconomy Council) |
Advisory Board member |
acatech – Deutsche Akademie der Technikwissenschaften |
Germany |
von Braunmühl, Benedikt (Rentschler 202309– CEO before HMNC Brain Health + Medicover AB + Qiagen + Chiron Vaccines) |
Chief Executive Officer (CEO) |
Rentschler (Group) |
Germany |
von Capeller, Gaudenz (Cellestia Biotech 201707– CFO Piqur Therapeutics 201507 CEO) |
Chief Financial Officer (CFO) |
Cellestia Biotech AG |
Switzerland |
von Dahlen, Guido (LabWare 201003 Sales Manager Life Science) |
Sales Manager / Marketing Manager |
LabWare (Group) |
Germany |
von Dalwigk, Friedrich (Analyticon Biotechnologies 2007 CEO) |
Chief Executive Officer (CEO) |
Analyticon Biotechnologies AG |
Germany |
von Dalwigk, Reinhard (Analyticon Biotechnologies 201105 Executive Board Chairman) |
Board member, executive |
Analyticon Biotechnologies AG |
Germany |
von Degenfeld, Georges (iAtros GmbH 202003 Managing Director + Co-Founder) |
Managing Director |
iAtros GmbH |
Germany |
von der Mülbe, Florian (CureVac 201706 COO + Co-Founder) |
Chief Operating Officer (COO) |
CureVac (Group) |
Germany |
von der Osten, Dinnies Johannes (GoodVent 201109 Managing Director (geschäftsf Kommanditist)) |
Managing Director |
GoodVent Beteiligungsmanagement GmbH & Co KG |
Germany |
von der Weid, Sandya (LifeSci Advisors 202101 before Debiopharm) |
n. a. |
LifeSci (Group) |
United States (USA) |
von Eggeling, Ferdinand (Univ Jena 201112 Professor) |
Professor |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
von Einem, Christoph (White & Chase 200809 Munich) |
n. a. |
White & Case (Group) |
Germany |
von Emster, Kurt (Abingworth 201507– Managing Partner joined 201501 before venBio + MPM Capital + Franklin Templeton) |
Managing Partner (investment firm) |
Carlyle (Group) |
United States (USA) |
von Frankenberg, Alex (High-Tech Gründer Gründerfonds 201209 Managing Director) |
Managing Director |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
von Gabain, Alexander (Intercell 200311) |
n. a. |
Valneva (Group) |
Austria |
von Glass, Birgitta (BioM 201804 Marketing + Communications) |
Public Relations Manager / Investor Relations Manager |
Bavaria (govt region) |
Germany |
von Gordon, Judith (Boehringer Ingelheim 201405 Head of Global Media + PR) |
Public Relations Manager / Investor Relations Manager |
Boehringer Ingelheim (Group) |
Germany |
von Grotthuss, Moritz (Immungenetics GmbH 201101 Managing Director) |
Managing Director |
Innoveas (Group) |
Germany |
von Halem, Carl (Xlife Sciences 202112– CFO before CommneX + SaEnergy Systems) |
Chief Financial Officer (CFO) |
Xlife Sciences AG (SIX: XLS) |
Switzerland |
von Heijne, Johan (Ratos 201501 CEO of Biolin Scientific) |
Chief Executive Officer (CEO) |
Ratos (Group) |
Sweden |
von Herrmann, Bruce (Agilent 200708 General Manager + VP Software Div) |
General Manager (management) |
Agilent (Group) |
United States (USA) |
von Hohenthal, Balthasar (Spitality GmbH 201809– Managing Director + Co-Founder before KSB Klinkberatung) |
Managing Director |
Spitality GmbH |
Germany |
von Horsten, Hans Henning (HTW Berlin 201505 Professor at Dept Engineering II, SG Life Sciene Engineering) |
Professor |
HTW Berlin – Hochschule für Technik und Wirtschaft Berlin (University of Applied Sciences Berlin) |
Germany |
von Hummel, Julia (MC Services 201811) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
von Keutz, Eckhard (Lena Biosciences 202308– Advisory Board Member formerly bayer Pharmaceuticals) |
Advisory Board member |
Lena Biosciences Inc. |
United States (USA) |
von Keyserling, Helmut (SpreeLabs 201106 Managing Director + Co-founder) |
Managing Director |
SpreeLabs UG (haftungsbeschränkt) |
Germany |
von Klitzing, Bettina (4SC 200901 Manager Public Realtions + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
4SC (Group) |
Germany |
von König, Cajetan (Miracor 201407– Director of Sales + Marketing) |
Sales Manager / Marketing Manager |
Miracor (Group) |
Austria |
von Laer, Dorothee (ViraTherapeutics 201609 CEO + Scientific Founder) |
Chief Executive Officer (CEO) |
Boehringer Ingelheim (Group) |
Austria |
von Leoprechting, Achim (Tecan 201904– CEO joined 201310 before PerkinElmer + Packard Bioscience) |
Business Development Manager / Strategy Manager |
Tecan (Group) |
Switzerland |
von Loeper, Philipp (Eppendorf 201606– Chair of Supervisory Board joined Supervisory Board in 2011) |
Supervisory Board Member |
Eppendorf (Group) |
Germany |
von Mangoldt, Karl (Protembis GmbH 2013– Managing Director + Co-Founder) |
Managing Director |
Protembis GmbH |
Germany |
von Matuschka, Agnes (Potsdam Science Park 202305 Managing Director) |
Managing Director |
Potsdam Science Park (Standortmanagement Golm GmbH) |
Germany |
von Mehring, Christian |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
von Meiborn, Wolfgang (Bird & Bird 200809) |
n. a. |
Bird & Bird (Group) |
Germany |
von Meier, Sandra (Merck (DE) 201404– Director Bus Dev Oncology before Medigene) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
von Messling, Veronika (Germany (govt) 202306 Ministerial Director of BMBF) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
von Rickenbach, Josef (Parexel 201706 CEO) |
Chief Executive Officer (CEO) |
Parexel (Group) |
United States (USA) |
von Roeder, Helene (Merck (DE) 202403 CFO) |
Chief Financial Officer (CFO) |
Merck (DE) (Group) |
Germany |
von Rundstedt, Friederike (Bock Bio Science 200906 Managing Director) |
Managing Director |
Bock Bio Science (Group) |
Germany |
von Rüden, Thomas (Direvo Biotech –201004 CEO STEPPED DOWN 4/19 before MorphoSys) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |
von Schacky, Clemens (Omegametrix GmbH 201807 Managing Director) |
Managing Director |
Omegametrix GmbH |
Germany |
von Schroeders, Nikolai (Spitality GmbH 201809– Co-Founder before KSB Klinkberatung) |
Managing Director |
Spitality GmbH |
Germany |
von Schulthess, Konstantin (CDR-Life 202204 CFO) |
Chief Financial Officer (CFO) |
CDR-Life AG |
Switzerland |
von Schultzendorff, Leopold (Docflix 202306 Managing Director + Co-Founder) |
Managing Director |
Docflix GmbH (Doctorflix) |
Germany |
von Schönfels, Philipp (Alcedo Biotech 200612 Managing Director) |
Managing Director |
Alcedo Biotech GmbH |
Germany |
von Siemens, Björn (Caresyntax 202402 CFO + Co-Founder) |
Chief Financial Officer (CFO) |
Caresyntax (Group) |
Germany |
von Velasco, Sabine (ERC GmbH 201106 Marketing) |
Sales Manager / Marketing Manager |
ERC Gesellschaft für den Vertrieb wissenschaftlicher Geräte mbH (ERC GmbH) |
Germany |
von Volkmann, Christian (MagForce 201205– Head of Finance before Jerini CFO + Ernst & Young) |
Chief Financial Officer (CFO) |
MagForce (Group) |
Germany |
von Walcke-Wulffen, Vincent-Joachim (BioKryo GmbH 201110 Managing Director) |
Managing Director |
Air Liquide (Group) |
Germany |
von Wardenburg, Niels (Teneura 202407 Founder) |
Company Founder |
Teneura (DE) |
Germany |
Vonder Mühll, Daniel (SystemsX.ch 201104 Managing Director) |
Managing Director |
SystemsX.ch project (CH, 2004) |
Switzerland |
Vonlanthen, Nadine (Basilea 201211 Licensing Manager, BusDev + Licensing) |
Business Development Manager / Strategy Manager |
Basilea (Group) |
Switzerland |
Vonnahme, Marcel (eCapital 2012 201211 Investment Manager) |
Investment Manager |
eCapital (Group) |
Germany |
Vonnemann, Jonathan (Scitaris 202204 Managing Partner) |
Managing Partner |
Scitaris (Group) |
Germany |
Vorbrodt, Hans-Matthias (Orgentis Chemicals GmbH 201102 Managing Director) |
Managing Director |
Orgentis Chemicals GmbH |
Germany |
Vorm, Ole (Evosep 202301 Founder before Bruker + Thermo Fisher + Proxeon) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Evosep ApS |
Denmark |
Vormschlag, Knud (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
Vornlocher, Hans-Peter (Roche Kulmbach 200809 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
LGC (Group) |
Germany |
Vorwachs, Viktoria (Niedersachsen (govt) 202407 Investment Manager at NBank Capital) |
Investment Manager |
Niedersachsen (govt region) |
Germany |
Vos, Alexander (VectorY 202106– CEO before VarmX + Paion + Genzyme Europe + PharmaCell) |
Chief Executive Officer (CEO) |
VectorY (Group) |
Netherlands |
Voss, Hartmut (MCG Motion Capture 201910 Managing Director) |
Managing Director |
MCG Motion Capture GmbH (Motion Capture Group) |
Germany |
Voss, Jörn (Fassisi 201102 Managing Director) |
Managing Director |
Fassisi, Gesellschaft für Veterinärdiagnostik und Umweltanalysen mbH |
Germany |
Voswinkel, Stephan (MLM Medical Labs 202010 Managing Director) |
Managing Director |
MLM Medical Labs (Group) |
Germany |
Vuagniaux, Gregoire (Debiopharm 201905 Director of Translational Science) |
n. a. |
Debiopharm (Group) |
Switzerland |
Vujevic, Manuela (InSphero 201311 Head of Marketing Communications) |
Sales Manager / Marketing Manager |
InSphero (Group) |
Switzerland |
Vulto, Paul (Mimetas 201708 Managing Director) |
Managing Director |
Mimetas B.V. |
Netherlands |
Vunder, Kadri (Aravis 201307– Partner in life science team before LSVenture) |
Managing Partner (investment firm) |
Aravis (Group) |
Switzerland |
Vögtli, Martin (Sal Oppenheim 200809 Analyst) |
Analyst (Financial / Industry) |
Sal. Oppenheim (Group) |
Germany |
Völker, Lutz (Molecular Health 201511 CEO) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
Germany |
Völker, Sonja (Bayern (govt) 201301 Project Manager at IBB Netzwerk GmbH) |
n. a. |
Bavaria (govt region) |
Germany |
Völker-Albert, Moritz (EpiQMAx GmbH 201903 Managing Director + Co-Founder) |
Managing Director |
Moleqlar Analytics GmbH |
Germany |
Vössing, Dagmar (Karlsruhe Institute of Technology 201307 Head Business Development) |
Business Development Manager / Strategy Manager |
Karlsruhe Institute of Technology (KIT) |
Germany |
Wachenfeld, Joachim (Vossius & Partner 200310–200708–) |
n. a. |
Vossius & Partner patent attorneys |
Germany |
Wachsmuth, Malte (Bruker 202301 Managing Director for Luxendo Light Sheet Microscopy Business) |
Managing Director |
Bruker (Group) |
Germany |
Wacker, Michael (BioMedPartners 202007 before Polyneuron 201805– CBO before GlycoVaxyn CSO + Co-Founder) |
Chief Business Officer (CBO) |
BioMedPartners (Group) |
Switzerland |
Wacker, Peter-Alexander (Wacker 200501 CEO) |
Chief Executive Officer (CEO) |
Wacker (Group) |
Germany |
Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) |
Business Development Manager / Strategy Manager |
SGS (Group) |
Switzerland |
Waddington, Simon (Evolva 201707–201807 CEO before COO before Abunda Nutrition CEO RESIGNED 7/18) |
Chief Executive Officer (CEO) |
Lallemand (Group) |
Switzerland |
Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) |
Public Relations Manager / Investor Relations Manager |
Agilent (Group) |
United States (USA) |
Wadzack, Jörg |
n. a. |
Humangenomprojekt (DE) |
Germany |
Wagemann, Bernd (Scienion 200312 Scientific Advisory Board) |
Advisory Board member |
Bico (Group) |
Germany |